April 21, 2015
SAN DIEGO, CA -– Invetech, a global leader in instrument design and development, custom automation, and contract manufacturing, and NanoCellect Biomedical, a company developing affordable and accessible flow cytometry and cell sorting technology for life science researchers, today announced a collaboration to develop a novel flow cytometry platform. Headquartered in San Diego, NanoCellect Biomedical has [...]
April 21, 2015
Pleasanton, CA and Redwood City, CA -— Bina Technologies, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and AstraZeneca (NYSE: AZN) today announced that they have entered into an agreement for AstraZeneca to become the first member to join the Bina Alliance Program and to further develop the Bina Genomic Management [...]
April 20, 2015
Hamburg, Germany -– Eppendorf AG's new app offers a variety of useful aids for everyday laboratory work in addition to product information that has been optimized for mobile devices. "Making daily laboratory work easier for our users: that's the comprehensive claim we want mobile users to experience with our new app," says Frank Thormählen, Director [...]
April 20, 2015
CARLSBAD, Calif. -- Translational and clinical research laboratories now have access to a multi-biomarker, next-generation sequencing (NGS) panel that includes 52 solid tumor genes associated with current oncology drugs and published evidence. The Oncomine Focus Assay by Thermo Fisher Scientific (NYSE: TMO) is being featured at the American Association for Cancer Research conference taking place [...]
April 20, 2015
BILLERICA, Mass. — — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced global availability of the ThunderBolts Myeloid Panel, a next-generation sequencing (NGS) research assay designed to rapidly detect and cost-effectively analyze genetic mutations associated with AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndromes), MPN (Myeloproliferative Neoplasms) and [...]
Horizon Discovery Group plc and Thermo Fisher Scientific Sign Supply and Commercialisation Agreement
April 20, 2015
Cambridge, UK -- Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, today announced it has signed a supply and commercialisation agreement with Thermo Fisher Scientific, the world leader in serving science. Under the terms of the agreement, [...]
April 20, 2015
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT:BTX) and its subsidiary OncoCyte Corporation today announced positive clinical results of PanC-Dx™, OncoCyte’s class of proprietary, non-invasive cancer diagnostic tests, in detecting the most common type of bladder cancer, urothelial carcinoma (UC). Karen B. Chapman, PhD, Vice President of Research at OncoCyte, presented the results from two prospective [...]
Agilent Technologies, Inc. Recommends Stockholders Reject TRC Capital’s “Mini-Tender” Offer
April 20, 2015
SANTA CLARA, Calif. -- Agilent Technologies, Inc. (NYSE: A) has received notice of an unsolicited mini-tender offer by TRC Capital Corporation to purchase up to 2.5 million shares, or about 0.75%, of Agilent Technologies, Inc. outstanding common stock at a price of $41.55 per share in cash. As TRC Capital's own offer document acknowledges, the [...]
Bruker Introduces Next-Generation GigaHertz NMR Technology at ENC 2015
April 20, 2015
ASILOMAR, Calif. -- At the 56th Experimental Nuclear Magnetic Resonance Conference (www.enc-conference.org),Bruker announced it is launching its next-generation of GHz-class NMR technology, with a combination of major method and instrumentation advances, which enable even more advanced scientific and translational research in structural biology, drug discovery and the study of macromolecular complexes. The primary focus of [...]
April 20, 2015
Foster City, CA -- PointCross Life Sciences today announced a strategic partnership with InterpretOmics Pvt. Ltd. to provide an integrated Big Data and globally accessible environment for genomic interpretation and analysis of all biomarkers collected in the context of clinical trials and nonclinical studies. This platform will serve the needs of precise or multi-targeted drug [...]
